Fuda Cancer Hospital - Malaysia

Fuda Cancer Hospital - Malaysia Fuda is committed to providing cancer patients around the world with the best medical care. There are totally 400 beds, of which 45 are VIP wards .
(1)

Located in Tianhe District (North Campus) and Haizhu District (South Campus) of Guangzhou City, Fuda Cancer Hospital is under the jurisdiction of Health supervision bureau of Guangdong Province, a bureau that mostly regulates government founded hospitals. Fuda is an affiliated hospital to Jinan University and is the Translational Medicine Center of Guangzhou Institute of Biomedicine and Health of Chinese Academy of Sciences. Fuda operates under the international standards, and was selected as the National Key Clinical Speciality hospital (Oncology) in 2010. Fuda has several highly efficient and professional teams: cryosurgical ablation team, micro-vascular intervention team, immunotherapy team, surgical teams for head-neck, chest and a team for hepato-biliary cancer. The Joint Commission International (JCI), one of the most widely recognized hospital evaluation system, accredited Fuda Cancer Hospital in 2013. In Fuda, we value technology, integrity and humanity. Life is what we hold dear here. Fuda has been providing patients around the world with high-tech, world-class medical services. With all the miracles and success made in the past decade, Fuda is striving to reach the ultimate goal to become a hospital that is specialized in most novel cancer treatment, equipped with advanced medical instrument and focuses on cutting-edge oncological science. In the past decade, Fuda has been using latest cancer-treating technologies to treat patients who were in early or advanced stage of cancer. Fuda's treatment has helped patients by significantly prolonging patient’s survival time and improving life quality. Fuda has developed a unique “3C+P” treatment model, which is, cryosurgical ablation (CSA), CANCER MICRO-VASCULAR INTERVENTION (CMI), COMBINED IMMUNOTHERAPY FOR CANCER (CIC), AND PERSONALIZED TREATMENTS (P). So far, Fuda has had more than 10,000 cases of cryosurgical ablation, which ranks No.1 in the world in terms of quantity as well as the types of cancer treated. Fuda has attracted cancer patients from more than 70 countries around the world, 70 percent of patients from foreign countries in South-East Asia, the Middle East, Oceanic, Europe and North America. Fuda has received various awards in China and abroad for outstanding achievements in treating cancer and been highly praised by patients around the world.

11/04/2026
11/04/2026

当被告知“癌症”…
你是否也感到无助与迷茫?
现在,有新的希望。
🔬 最新无创与微创癌症治疗技术
👨‍⚕️ 与权威专家面对面交流
💡 个性化治疗方案,效果更好、副作用更小
📅 4月11日 上午10:00
📍 Zoom link⏬️ https://us06web.zoom.us/j/83627992776?pwd=rZV6XD43L0zJ6vLGBMrgwF2YyKIUYM.1

NextGen Cancer ConversationsDiscover Minimally Invasive Treatments ✨ Real stories shared by FUDA patients探索微创治疗|聆听晚期患者的抗...
08/04/2026

NextGen Cancer Conversations
Discover Minimally Invasive Treatments
✨ Real stories shared by FUDA patients

探索微创治疗|聆听晚期患者的抗癌之路
✨ 复大病患亲身分享
📞 Contact / 报名热线:016-608 1955

29/03/2026

【Minimally Invasive Treatment】【Lung Nodule -Cryoablation】
>>>Cryoablation of Lung Nodule in an 82-Year-Old Veteran> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

[Fuda News | International Conference]Frontiers Converge: President Niu Lizhi Attends the 2026 IO&E Physician Advisory B...
28/03/2026

[Fuda News | International Conference]
Frontiers Converge: President Niu Lizhi Attends the 2026 IO&E Physician Advisory Board Meeting
From March 13 to 14, the 2026 International Oncology & Embolization Physician Advisory Board Meeting (2026 IO&E SAB) was held in Minnesota, USA. The meeting brought together 24 leading experts from around the world to explore cutting-edge technologies and jointly shape the future of the field.

In recognition of his profound expertise in minimally invasive cancer therapies and his strong international reputation, President Niu Lizhi of Guangzhou Fuda Cancer Hospital was invited to attend as one of five representatives from Asia. During the meeting, he engaged in in-depth discussions and academic exchanges with top scholars from the United States, Europe, and across Asia, focusing on the latest advancements in interventional oncology and tumor ablation. He also shared valuable insights drawn from China’s clinical experience, combining practical expertise with innovative thinking.

△ President Niu Lizhi with Professor Matthew from Mayo Clinic, recalling their interaction and photo at the WCIO conference 10 years ago

△ President Niu Lizhi with Professor Koichiro Yamakado, President of the Japan Radiological Society

△ President Niu Lizhi discussing the development of cryoablation technology with a technical expert from Boston Scientific
Academic progress knows no borders, and collaboration drives innovation. This SAB meeting was not only a platform for exchanging cutting-edge knowledge, but also an opportunity to deepen international cooperation. President Niu’s participation reflects the growing global recognition of China’s advancements in minimally invasive cancer treatment. Through this platform, a strong and confident “China voice” was shared with the world, highlighting the capabilities of Chinese medical institutions in the field of interventional oncology and ablation.

“Through in-depth exchanges with leading experts worldwide, we have gained a more comprehensive understanding of the latest developments and future trends in cancer diagnosis and treatment,” said President Niu. “We will integrate these cutting-edge insights into our clinical practice, striving to provide more advanced technologies and higher-quality care to better safeguard the lives and health of every cancer patient.”

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

【复大新闻】【国际会议】前沿碰撞,全球对话!牛立志院长出席2026 IO&E 国际专家顾问会3月13日至14日,2026年肿瘤介入与栓塞国际专家顾问会(2026 IO&E SAB)在美国明尼苏达州召开。本届SAB汇聚了24位国际权威专家,旨...
28/03/2026

【复大新闻】【国际会议】
前沿碰撞,全球对话!牛立志院长出席2026 IO&E 国际专家顾问会
3月13日至14日,2026年肿瘤介入与栓塞国际专家顾问会(2026 IO&E SAB)在美国明尼苏达州召开。本届SAB汇聚了24位国际权威专家,旨在探讨技术前沿、共筑未来蓝图。

凭借在肿瘤微创治疗领域的深厚造诣与广泛的国际影响力,广州复大肿瘤医院牛立志院长作为五位亚洲专家代表之一受邀出席。会议期间,他与来自美国、欧洲及亚洲地区的顶尖学者同台论道,围绕肿瘤介入与消融的前沿学术问题,展开了深度对话与思想碰撞,分享了兼具中国智慧与实战价值的宝贵经验。

△牛立志院长与梅奥医院Matthew教授,10年前曾在WCIO会议有过交流合影

△牛立志院长与日本放射学会主席Koichiro Yamakado合影留念

△牛立志院长与波科技术专家讨论冷冻消融技术的发展
学术无国界,交流促革新。此次SAB之行,不仅是一次前沿知识的碰撞之旅,更是一次国际交流合作的深化之旅。牛立志院长的出席,不仅代表着国际学术界对中国肿瘤微创技术发展的认可,更通过这一平台,成功向世界发出了掷地有声的“中国声音”,生动展现了中国医疗机构在肿瘤介入与消融领域的实力。

“通过与全球顶尖专家的深入交流,我们对国际肿瘤诊疗的最新进展与未来趋势有了更全面的认知。”牛立志院长表示,“我们将把前沿理念与我院临床实践深度融合,以更精湛的技术、更优质的服务,切实守护每一位肿瘤患者的生命健康。”
點擊了解更多患者故事
>>> https://hongkong.fudahospital.com/

您可以通過以下方式聯絡我們:
☎️電話: +60 19 996 4656
🌟Whatsapp: +60 19 996 4656
🌍網站: https://hongkong.fudahospital.com

【patient’s story】【China- cervical cancer- interventional chemotherapy】From “Deserter” to “Returning to the Front”: A 15-...
27/03/2026

【patient’s story】【China- cervical cancer- interventional chemotherapy】
From “Deserter” to “Returning to the Front”: A 15-Year Journey of a Cervical Cancer Patient
On the long road of fighting cancer, Ms. Li (pseudonym) admits that she was once a disobedient “deserter.” Yet somehow, this “deserter” was pulled back to the battlefield again and again—by her family, by her doctors, and by the small but persistent will to live that never truly faded.
Her story began 15 years ago.
Ms. Li comes from the grasslands of Inner Mongolia. That year, she went to a local hospital because of vaginal dryness and pain. The diagnosis—“cervical cancer”—hit her life like a bullet.

In fact, there had been warning signs. Back in 2009, she had experienced contact bleeding, but she did not take it seriously.
Radical surgery for cervical cancer, radiotherapy, chemotherapy… After a round of intensive treatments, she endured it all. The cancer cells actually retreated. For more than seven years, her follow-up reports were mostly clear. This meant she had passed the “five-year safety period,” which usually indicates a high chance of long-term survival.
Ms. Li thought so too.
Gradually, she let her guard down. Smoking, drinking, playing mahjong—in the smoke-filled card rooms, she felt no different from anyone else. Life, she believed, should be lived with warmth and vitality.
What she did not know was that cancer cells often strike when vigilance fades.
It was in 2017 when Ms. Li caught a cold and developed a persistent cough that would not go away. Her family felt something was wrong and urged her to see a doctor. The doctor studied her scans for a long time. After learning about her history of cervical cancer, he advised her to go to a larger hospital for further examination.
“The doctor said there were many shadows in my lungs—maybe seven or eight,” she recalled.
She traveled to Harbin and Tianjin, visiting hospitals in two cities. Both gave the same diagnosis: lung metastases from cervical squamous cell carcinoma.
At that moment, Ms. Li broke down in tears. She thought the battle had long been over. She thought seven years without problems meant a lifetime without problems. She thought… but the cancer cells thought otherwise.
The next three years were painful. Systemic chemotherapy brought nausea, vomiting, hair loss, and fatigue—none of it spared her. Even worse, while enduring the suffering, she watched the nodules on her follow-up scans grow larger and more numerous.
Eventually, drug resistance developed, and the cough became uncontrollable. Ms. Li herself felt that enduring day after day was almost like waiting for death.
But her daughter refused to give up. She believed that in such a big world, there had to be a better solution.
Through a friend in Changchun, she learned about a treatment called cryoablation. That friend had once traveled to Japan for the same treatment but was not satisfied with the results. After returning to China, he found President Dr. Niu Lizhi at Fuda Cancer Hospital in Guangzhou, underwent cryoablation again, and finally achieved a satisfactory outcome.
Hearing this, Ms. Li’s daughter felt a spark of hope—like seeing a faint light in the darkness.
In October 2021, Ms. Li traveled south to Guangzhou and arrived at Fuda. But deep inside, she was anxious. Her condition seemed so serious—could it still be treated?
“Multiple metastatic tumors in both lungs, close to the right lower pulmonary artery, adhesions with the interlobar pleura and chest wall pleura…”
Based on her condition, the medical team performed two sessions of cryoablation for lung metastases, along with needle biopsies. The biopsy results once again confirmed: metastases from the original cervical cancer.
After the procedures, Ms. Li continued with chemotherapy and immunotherapy. For more than a year afterward, her disease remained stable.
But once things stabilized, Ms. Li’s thoughts began to wander again.
“If it’s stable, isn’t that good enough? Maybe I don’t need further treatment.”
Then in January 2024, the tumors grew again.
Ms. Li returned to Fuda and underwent a third cryoablation procedure. However, there were too many nodules, and some continued to enlarge. She subsequently received three iodine-125 seed implantations, which finally reduced the tumors.
Just as her attending doctor suggested consolidating the treatment with interventional chemotherapy, Ms. Li’s “escape plan” resurfaced once more.

“I had seen other patients undergo interventional therapy before—the reactions looked severe… I was scared,” she said. This time, she truly wanted to give up. After so many cycles of treatment and recurrence, she was exhausted.
Then one day, Ms. Li received a call from her attending physician, Dr. Yang Ting.
The voice on the other end was as gentle and calm as always:
“Ms. Li, it’s time for your treatment. Please come back.”
Just that single sentence left her stunned for a long time.
Her family continued persuading her. At that moment, she thought about her young child and about how many patients in their seventies and eighties were still fighting. Why shouldn’t she keep going?
The interventional treatment turned out to be far less frightening than she had imagined—and the results surprised her.
The lung metastases shrank. The lymph nodes also shrank. Even the cough that had troubled her for years almost disappeared.
“Director Zhong Xiaojun from the interventional department knew I was very scared, so he chatted with me the whole time. Before I even realized it, the procedure was already done,” she said.
Fifteen years have passed. For Ms. Li, it feels like fighting three battles.
In the first battle, she won—and became careless.
In the second battle, she lost—and nearly gave up.
In the third battle, she is still fighting.
She once ran away from the battlefield, a “deserter” in her own words. But time and again, she was pulled back.
And this time, she finally sees the dawn of victory.
Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

【患者故事】【中国-宫颈癌-介入】从“逃兵”到“归队”:一位宫颈癌患者的15年在抗癌这条路上,李姐(化名)自认是个不听话的“逃兵”。可偏偏,这个“逃兵”一次又一次被拽回了战场——被家人,被医生,也被那一丝从未熄灭的求生欲。故事要从15年前说...
27/03/2026

【患者故事】【中国-宫颈癌-介入】
从“逃兵”到“归队”:一位宫颈癌患者的15年
在抗癌这条路上,李姐(化名)自认是个不听话的“逃兵”。可偏偏,这个“逃兵”一次又一次被拽回了战场——被家人,被医生,也被那一丝从未熄灭的求生欲。
故事要从15年前说起。
李姐来自内蒙古大草原。那一年,她因阴道干痛到当地医院检查。结果“宫颈癌”三个字,像一颗子弹,击穿了她的生活。

其实,她并非毫无预兆,2009年就曾有过接触性出血,可她并没往心里去。
宫颈癌根治术、放疗、化疗……一轮狂轰滥炸之后,她扛住了。癌细胞居然真的偃旗息鼓了。七年多,复查单上基本清清爽爽。这意味着过了“五年安全期”,基本就算“胜了”。
李姐也是这么想的。
于是,她开始放松警惕了。抽烟、喝酒、打麻将,烟雾缭绕的棋牌室里,她觉得自己和正常人没什么两样。日子嘛,就该这样热气腾腾地过。
可她不知道的是,癌细胞这东西,最“爱”趁虚而入。
那次是2017年,李姐因一场感冒,出现了久咳不愈。家里人觉得不对劲,催着她去医院。医生盯着她的片子看了很久,在得知李姐曾得过宫颈癌后,让她到大医院再检查一下。“医生说我肺上阴影特别多,可能有七八个。”
哈尔滨,天津,她跑了两座城市,得到了同一个答案:宫颈鳞癌肺转移。
那一刻,李姐崩溃到嚎啕大哭。她以为那场仗早就打完了。她以为七年没事,就是一辈子没事。她以为……可癌细胞不这么以为。
接下来的三年,是痛苦的三年。全身化疗,恶心、呕吐、脱发、乏力,一样没落下。更绝望的是,一边受着罪,一边看着复查报告上的结节——增大、增多。
后来,耐药了,咳嗽也止不住。李姐自己都觉得,这样一天天挨着,简直就像在等死似的。但女儿不甘心。她不信,偌大的世界,就没有更好的法子?
辗转间,她通过长春的朋友,听说了一种叫“冷冻消融”的技术。这位朋友曾到日本做了同样的治疗,效果不太理想,回国后找到广州复大肿瘤医院的牛立志院长,又做了一次冷冻消融,这次终于收获了满意的效果。
女儿听得心里一动,像在黑暗里看到了一丝光亮。2021年10月,李姐南下广州,来到复大。心里却忐忑自己这么严重,不知道能不能治。
“双肺多发转移瘤,临近右下肺动脉、叶间胸膜、胸壁胸膜粘连……”针对李姐的病情,医疗团队先后为她实施了2次肺转移瘤冷冻消融术,并同步穿刺活检,活检结果再次证实为:原宫颈癌转移。
术后李姐配合化疗及免疫治疗。在之后的一年多,她的病情控制稳定。但一稳定,李姐的心思又开始“活络”了:稳定了不就好了吗?那就不用再治疗了。
结果,2024年1月,肿瘤又长大了。
李姐再次返回复大,接受第3次冷冻消融。可结节太多,部分结节还是有所增大,她又先后进行了3次碘粒子植入,肿瘤总算有所缩小。可主管医生刚建议再做介入化疗巩固一下,李姐的“逃跑计划”又启动了。


△三次碘粒子植入前(左图)后(右图)对比
“我之前看到别的患者做介入,反应大……我怕。”这一次,她真的想放弃了。一次又一次,反反复复,她累了。
直到某一天,李姐接到主管医生杨婷的电话。电话那头的声音,还是那么亲切温和,那么不急不缓:“李姐,治疗时间到了,该过来了。”
就这一句话,她愣了很久。身边的家人还在劝说,那一刻她想着,孩子还小,她还年轻,别人七八十还在治,她为什么不再坚持?
介入并没有她想象中那么可怕,结果也令她意外:双肺转移瘤缩小了,淋巴结也缩小了,这么多年的咳嗽,也不怎么咳了。“那位介入科钟小军主任知道我特别害怕,就跟我唠嗑,我都还没反应过来,就做好了。”
十五年了,李姐就像打了三场仗。第一场,打赢了,她飘了;第二场,打输了,她差点放弃;第三场,打到现在,还在打。她当过“逃兵”,又一次被拽回了战场。而这一次,她终于看见了胜利的曙光。

點擊了解更多患者故事
>>> https://hongkong.fudahospital.com/

您可以通過以下方式聯絡我們:
☎️電話: +60 19 996 4656
🌟Whatsapp: +60 19 996 4656
🌍網站: https://hongkong.fudahospital.com

26/03/2026

【患者故事】【香港-舌癌颈部转移-介入+碘粒子植入】
>>> 從「唔成人樣」到走出陰霾:香港舌癌患者絕處逢生> https://hongkong.fudahospital.com/

您可以通過以下方式聯絡我們:
☎️電話: +60 19 996 4656
🌟Whatsapp: +60 19 996 4656
🌍網站: https://hongkong.fudahospital.com

26/03/2026

【Paitent’s Story】【Hong Kong - Tongue Cancer - Interventional Chemotherapy+ Brachytherapy】
>>>From Desperation to Recovery: A Hong Kong Patient’s Fight Against Tongue Cancer> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

🩺 肿瘤筛查 8折优惠!早期发现,健康无忧!💪 Early detection saves lives! Get 20% off on cancer screening.📅 限时优惠,马上预约!Book now!
19/03/2026

🩺 肿瘤筛查 8折优惠!早期发现,健康无忧!
💪 Early detection saves lives! Get 20% off on cancer screening.
📅 限时优惠,马上预约!Book now!

Address

Level 27-05, Tower B, Pavilion Embassy, 200 Jalan Ampang
Kuala Lumpur
50450

Telephone

+60199964656

Website

https://english.fudaguangzhou.com/

Alerts

Be the first to know and let us send you an email when Fuda Cancer Hospital - Malaysia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Fuda Cancer Hospital - Malaysia:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category